<DOC>
	<DOC>NCT01515826</DOC>
	<brief_summary>The purpose of this study is to compare VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.075%) ophthalmic gel to VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.1%) ophthalmic solution in the prevention of postoperative inflammation and infection.</brief_summary>
	<brief_title>VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>18 years of age or older. Diagnosis of cataract with intention to undergo routine, uncomplicated cataract surgery. Able to understand and sign an informed consent form. Other protocoldefined inclusion criteria may apply. Glaucoma or ocular hypertension. Use of topical or systemic nonsteroidal antiinflammatory drugs (NSAIDs) within 14 days prior to surgery or planned use during the study. Lowdose acetylsalicylic acid (up to 100 mg/day) is allowed. Use of antibacterial, antiviral, or antifungal agents or ocular medications within 30 days prior to enrollment in the study or during study, as specified by protocol. Secondary implantation or replacement of the intraocular lens (IOL) in the study eye. Planned use of contact lenses in the study eye during the study period. Cataract surgery in the contralateral eye within 30 days prior to the Screening Visit, or planned for the 3 weeks after the cataract surgery in the study eye. History of clinically significant trauma to the study eye within the past 12 months. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Cataract surgery</keyword>
	<keyword>Topical therapy</keyword>
	<keyword>Prevention of inflammation</keyword>
	<keyword>Inflammation of infection</keyword>
</DOC>